Investment Strategy and Policies - The company prioritizes redeemable wealth management products in its investment strategy to maintain capital preservation and liquidity[3] - The company implements treasury policies, internal control policies, and rules for wealth management product investments to ensure sufficient working capital for business operations, R&D, and capital needs[3] - Investment decisions are made on a case-by-case basis after considering factors such as investment duration and expected returns[3] China Construction Bank Structured Product - The company holds a China Construction Bank structured product with an original principal amount of RMB 111,826 thousand and a fair value of RMB 113,440 thousand as of December 31, 2023, representing 9.72% of the group's total assets[2] - The China Construction Bank product generated an unrealized gain of RMB 1,614 thousand for the year ended December 31, 2023[2] - The China Construction Bank product is a low-risk, non-principal-guaranteed floating income fixed-income product without regular interest income distribution[2]
绿竹生物-B(02480) - 2024 - 年度业绩